| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB-ADAZ | 191 |
| 1 | DICLOFENAC SODIUM | 190 |
| 2 | LEFLUNOMIDE | 190 |
| 3 | SECUKINUMAB | 188 |
| 4 | DICLOFENAC | 185 |
| 5 | ADALIMUMAB | 171 |
| 6 | DICLOFENAC SODIUM 1% | 171 |
| 7 | DICLOFENAC SODIUM TOPICAL | 171 |
| 8 | DICLOFENAC SODIUM TOPICAL GEL, 1% | 171 |
| 9 | ERENUMAB-AOOE | 170 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PYRIDOXINE HYDROCHLORIDE | 62 | 0.0227 |
| 1 | 12%AZELAIC ACID | 13 | 0.0155 |
| 2 | TRIPROLIDINE HYDROCHLORIDE | 3 | 0.0154 |
| 3 | SENNOSIDES, STIMULANT LAXATIVE | 1 | 0.0139 |
| 4 | DICLOFENAC POTASSIUM TABLETS | 120 | 0.0138 |
| 5 | BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY | 84 | 0.0136 |
| 6 | MAGNESIUM CITRATE ORAL SOLUTION | 84 | 0.0136 |
| 7 | MAGNESIUM CITRATE | 84 | 0.0133 |
| 8 | AZELAIC ACID | 13 | 0.0132 |
| 9 | PSEUDOEPHEDRINE HCL | 119 | 0.0109 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 212 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 197 |
| 2 | Antirheumatic Agent [EPC] | 190 |
| 3 | Interleukin-17A Antagonist [EPC] | 188 |
| 4 | Corticosteroid [EPC] | 182 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 166 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 154 |
| 7 | Aminosalicylate [EPC] | 147 |
| 8 | Vitamin C [EPC] | 142 |
| 9 | Interleukin-5 Antagonist [EPC] | 138 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 138 | 0.2006 |
| 1 | Endoglycosidase [EPC] | 12 | 0.0065 |
| 2 | Human C1 Esterase Inhibitor [EPC] | 21 | 0.0054 |
| 3 | Interleukin-17A Antagonist [EPC] | 188 | 0.0050 |
| 4 | Provitamin D2 Compound [EPC] | 89 | 0.0030 |
| 5 | beta3-Adrenergic Agonist [EPC] | 99 | 0.0021 |
| 6 | Antiseptic [EPC] | 8 | 0.0018 |
| 7 | Antirheumatic Agent [EPC] | 190 | 0.0018 |
| 8 | Aminosalicylate [EPC] | 147 | 0.0015 |
| 9 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 12 | 0.0014 |